诉讼核心信息 - 美国纽约东区联邦地区法院已对LifeMD公司提起集体诉讼 [7] - 诉讼代表在2025年5月7日至2025年8月5日期间购买或获得LifeMD证券的所有投资者 [7] - 投资者申请成为首席原告的截止日期为2025年10月27日 [7] 指控具体内容 - 指控称被告在集体诉讼期间做出了重大虚假或误导性陈述，且未能披露相关信息 [3] - 指控要点包括公司管理层大幅高估了LifeMD的竞争地位 [3] - 指控要点包括管理层在提高公司2025年业绩指引时存在鲁莽行为，未恰当核算RexMD业务部门不断增长的客户获取成本 [3] - 指控要点还包括管理层未恰当核算与销售肥胖治疗药物相关的客户获取成本，这些药物包括Wegovy和Zepbound [3] - 指控认为上述行为导致公司关于其业务、运营和前景的陈述在所有时间点均存在重大虚假误导或缺乏合理依据 [3]

集体诉讼案件概述 - 律师事务所Levi & Korsinsky通知LifeMD公司投资者有关一项证券集体诉讼 [1] - 该诉讼旨在为在2025年5月7日至2025年8月5日期间因涉嫌证券欺诈而遭受损失的LifeMD投资者挽回损失 [1] - 诉讼指控被告作出了虚假陈述和/或隐瞒了相关信息 [2] 诉讼指控内容 - 指控被告在实质上夸大了LifeMD的竞争地位 [2] - 指控被告在提高LifeMD公司2025年业绩指引时存在鲁莽行为 因其未恰当核算RexMD业务部门不断上升的客户获取成本 [2] - 指控被告未恰当核算与销售肥胖治疗药物相关的客户获取成本 包括Wegovy和Zepbound [2] - 基于以上原因 指控被告关于LifeMD业务 运营和前景的陈述在相关时期内存在实质性的虚假和误导性 和/或缺乏合理依据 [2]

, /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Class Period"). If you are a LifeMD investor and would like to learn more about this action, CLICK HERE  or please contact Berger Montague: Andrew Abramowitz at [email protected] or (215) 875-3015, or Caitlin Adorni at [ema ...

法律行动背景 - 律师事务所Faruqi & Faruqi正在调查针对LifeMD公司的潜在索赔，并提醒投资者关于联邦证券集体诉讼的牵头原告申请截止日期为2025年10月27日 [1] - 该诉讼指控公司及其高管违反了联邦证券法 [3] 具体指控内容 - 指控内容包括公司 materially overstated 其竞争地位 [3] - 指控公司在未恰当核算RexMD业务部门不断上升的客户获取成本以及减肥药物相关客户获取成本的情况下，reckless 地提高了其2025年业绩指引 [3] - 因此，公司关于其业务、运营和前景的陈述在所有相关时间均存在 materially false and misleading 和/或缺乏合理依据 [3] 股价波动与财务表现 - 2025年8月5日盘后，LifeMD公布了2025年第二季度财务业绩并修订了业绩指引 [4] - 公司将2025年总营收预期从原先的2.68亿至2.75亿美元下调至2.5亿至2.55亿美元 [4] - 在此消息公布后，2025年8月6日公司股价暴跌44.8% [4]

诉讼核心信息 - 律师事务所Levi & Korsinsky, LLP就LifeMD公司证券提起集体诉讼[1] - 诉讼旨在为在2025年5月7日至2025年8月5日期间因涉嫌证券欺诈而遭受损失的投资者挽回损失[1] - 投资者在2025年10月25日前可申请担任首席原告[3] 指控内容 - 指控被告对LifeMD的竞争地位进行了重大虚报[2] - 指控被告在提高公司2025年业绩指引时存在鲁莽行为 未恰当核算其RexMD业务部门不断上升的客户获取成本[2] - 指控被告未恰当核算与销售肥胖治疗药物相关的客户获取成本 包括Wegovy和Zepbound[2] - 因此 被告关于公司业务、运营和前景的陈述在所有相关时间均存在重大虚假和误导性且/或缺乏合理依据[2]

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), of the important October 27, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased LifeMD securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or c ...

Shareholders who purchased shares of LFMD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/lifemd-inc-loss-submission-form/?id=170976&from=4Â CLASS PERIOD: May 7, 2025 to August 5, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In LifeMD To Contact Him Directly To Discuss Their Options If you suffered losses in LifeMD between May 7, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading ...

LOS ANGELES, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 27, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR LIFEMD INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOU ...

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. ("LifeMD, Inc." or the "Company") (NASDAQ: LFMD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of LifeMD, Inc. investors who were adversely affected by alleged securities fraud between May 7, 2025 and August 5, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/lifemd-inc-lawsuit-submiss ...